Cargando…
Kinase Inhibitors as Potential Therapeutic Agents in the Treatment of COVID-19
Corona virus is quickly spreading around the world. The goal of viral management is to disrupt the virus’s life cycle, minimize lung damage, and alleviate severe symptoms. Numerous strategies have been used, including repurposing existing antivirals or drugs used in previous viral outbreaks. One suc...
Autores principales: | Naik, Rajashri R., Shakya, Ashok K., Aladwan, Safwan M., El-Tanani, Mohamed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9014181/ https://www.ncbi.nlm.nih.gov/pubmed/35444538 http://dx.doi.org/10.3389/fphar.2022.806568 |
Ejemplares similares
-
Exploring the chemotherapeutic potential of currently used kinase inhibitors: An update
por: Naik, Rajashri R., et al.
Publicado: (2023) -
Therapeutic Strategies in the Management of COVID-19
por: Naik, Rajashri R., et al.
Publicado: (2021) -
Therapeutic implications of current Janus kinase inhibitors as anti-COVID agents: A review
por: Jain, Nem Kumar, et al.
Publicado: (2023) -
Cyclin-Dependent Kinase Inhibitors and Their Therapeutic Potential in Colorectal Cancer Treatment
por: Thoma, Oana-Maria, et al.
Publicado: (2021) -
The Chemotherapeutic Potentials of Compounds Isolated from the Plant, Marine, Fungus, and Microorganism: Their Mechanism of Action and Prospects
por: Shakya, Ashok K., et al.
Publicado: (2022)